167 related articles for article (PubMed ID: 23555983)
1. The importance of gender-stratified antibiotic resistance surveillance of unselected uropathogens: a Dutch Nationwide Extramural Surveillance study.
den Heijer CD; Penders J; Donker GA; Bruggeman CA; Stobberingh EE
PLoS One; 2013; 8(3):e60497. PubMed ID: 23555983
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic resistance of Escherichia coli isolated from uncomplicated UTI in general practice patients over a 10-year period.
van Driel AA; Notermans DW; Meima A; Mulder M; Donker GA; Stobberingh EE; Verbon A
Eur J Clin Microbiol Infect Dis; 2019 Nov; 38(11):2151-2158. PubMed ID: 31440915
[TBL] [Abstract][Full Text] [Related]
3. Pediatric community acquired urinary tract infections due to extended-spectrum beta-lactamase versus non-extended-spectrum beta-lactamase producing bacteria.
Alsubaie MA; Alsuheili AZ; Aljehani MN; Alothman AA; Alzahrani AS; Mohammedfadel HA; Alnajjar AA
Pediatr Int; 2023; 65(1):e15620. PubMed ID: 37735838
[TBL] [Abstract][Full Text] [Related]
4. Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy.
Meier S; Weber R; Zbinden R; Ruef C; Hasse B
Infection; 2011 Aug; 39(4):333-40. PubMed ID: 21706226
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.
Cho YH; Jung SI; Chung HS; Yu HS; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K
Int Urol Nephrol; 2015 Jul; 47(7):1059-66. PubMed ID: 26026972
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
Arslan H; Azap OK; Ergönül O; Timurkaynak F;
J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
[TBL] [Abstract][Full Text] [Related]
7. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in hospital urinary tract infections: incidence and antibiotic susceptibility profile over 9 years.
Toner L; Papa N; Aliyu SH; Dev H; Lawrentschuk N; Al-Hayek S
World J Urol; 2016 Jul; 34(7):1031-7. PubMed ID: 26511749
[TBL] [Abstract][Full Text] [Related]
8. Extended spectrum beta lactamase producing organisms causing urinary tract infections in Sri Lanka and their antibiotic susceptibility pattern -A hospital based cross sectional study.
Fernando MM; Luke WA; Miththinda JK; Wickramasinghe RD; Sebastiampillai BS; Gunathilake MP; Silva FH; Premaratna R
BMC Infect Dis; 2017 Feb; 17(1):138. PubMed ID: 28187754
[TBL] [Abstract][Full Text] [Related]
9. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India.
Akram M; Shahid M; Khan AU
Ann Clin Microbiol Antimicrob; 2007 Mar; 6():4. PubMed ID: 17378940
[TBL] [Abstract][Full Text] [Related]
10. Does urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli show same antibiotic resistance when it recurs?
Ahn ST; Kim SW; Kim JW; Park HS; Moon DG; Oh MM
J Infect Chemother; 2019 Jul; 25(7):498-502. PubMed ID: 30852104
[TBL] [Abstract][Full Text] [Related]
11. Sex- and age-specific trends in antibiotic resistance patterns of Escherichia coli urinary isolates from outpatients.
McGregor JC; Elman MR; Bearden DT; Smith DH
BMC Fam Pract; 2013 Feb; 14():25. PubMed ID: 23433241
[TBL] [Abstract][Full Text] [Related]
12. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H
N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of gram-negative urinary tract infections caused by extended spectrum beta lactamases: pivmecillinam as a treatment option within South Dublin, Ireland.
O'Kelly F; Kavanagh S; Manecksha R; Thornhill J; Fennell JP
BMC Infect Dis; 2016 Nov; 16(1):620. PubMed ID: 27806687
[TBL] [Abstract][Full Text] [Related]
14. Stratification by demographic and clinical data of the antibiotic susceptibility of Escherichia coli from urinary tract infections of the community.
Grados MC; Thuissard IJ; Alós JI
Aten Primaria; 2019 Oct; 51(8):494-498. PubMed ID: 30104087
[TBL] [Abstract][Full Text] [Related]
15. Empiric antibiotic treatment for urinary tract infection in preschool children: susceptibilities of urine sample isolates.
Butler CC; O'Brien K; Wootton M; Pickles T; Hood K; Howe R; Waldron CA; Thomas-Jones E; Dudley J; Van Der Voort J; Rumsby K; Little P; Downing H; Harman K; Hay AD;
Fam Pract; 2016 Apr; 33(2):127-32. PubMed ID: 26984993
[TBL] [Abstract][Full Text] [Related]
16. Microbiology and Drug Resistance of Pathogens in Patients Hospitalized at the Nephrology Department in the South of Poland.
Michno M; Sydor A; Wałaszek M; Sułowicz W
Pol J Microbiol; 2018; 67(4):517-524. PubMed ID: 30550238
[TBL] [Abstract][Full Text] [Related]
17. Chronological change of antibiotic use and antibiotic resistance in Escherichia coli causing urinary tract infections.
Shigemura K; Tanaka K; Adachi M; Yamashita M; Arakawa S; Fujisawa M
J Infect Chemother; 2011 Oct; 17(5):646-51. PubMed ID: 21487942
[TBL] [Abstract][Full Text] [Related]
18. Incidence of multidrug resistance and extended-spectrum beta-lactamase expression in community-acquired urinary tract infection among different age groups of patients.
Fatima S; Muhammad IN; Usman S; Jamil S; Khan MN; Khan SI
Indian J Pharmacol; 2018; 50(2):69-74. PubMed ID: 30100654
[TBL] [Abstract][Full Text] [Related]
19. [In vitro activity of fosfomycin trometamol in the treatment of Escherichia coli related uncomplicated urinary tract infections].
Hoşbul T; Ozyurt M; Baylan O; Bektöre B; Ardiç N; Ceylan S; Erdemoğlu A; Haznedaroğlu T
Mikrobiyol Bul; 2009 Oct; 43(4):645-9. PubMed ID: 20084918
[TBL] [Abstract][Full Text] [Related]
20. [Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase producing urinary isolates of Escherichia coli in outpatients].
Marković T; Jeinić L; Smitran A; Petković M
Srp Arh Celok Lek; 2013; 141(11-12):775-9. PubMed ID: 24502096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
